Bowmark Capital has sold its majority interest in drug and alcohol testing services provider Medscreen Holdings Ltd to Concateno Plc, an AIM-listed company. The exit has generated an IRR of 52% and a return of 6.7x for Bowmark Capital.
GPs back energy supply services provider GreenYellow to support its expansion abroad
CapAgro is currently investing via its Innovation fund, which held a final close on €124m in 2017
Caledonia bought a 98.9% stake in the company for £117.2m and provided a short-term bridging loan
Nemera is valued at more than €1bn and will post a 2018 EBITDA of €70m, say reports